Log In
BCIQ
Print this Print this
 

NeoCart

  Manage Alerts
Collapse Summary General Information
Company Histogenics Corp.
DescriptionAutologous engineered neocartilage implant created outside the body using the patient's own cartilage cells integrated into a 3D collagen matrix
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentPhase III
Standard IndicationCartilage repair
Indication DetailsRepair knee cartilage injury
Regulatory Designation U.S. - Special Protocol Assessment (Repair knee cartilage injury)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/23/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today